Clinical trials: Angiography, Digital Subtraction
Cerebrovascular Disease
Application of QDSA Platform in Cerebrovascular Diseases
Cerebrovascular diseases pose a major global public health challenge, characterized by exceptionally high mortality and disability rates, with their pathogenesis closely linked to hemodynamic abnormalities.
- Trial name
- RADAR (NCT06902415)
- Testing
- QDSA (Quantitative Digital Subtraction Angiography)
- Where
- China
- Volunteers
- 1,000 people
- Sponsor
- Beijing Tiantan Hospital
Lung Cancer
Nano Drug Interventional Therapy Using Digital Subtraction Angiography（DSA） for Lung Carcinoma
The purpose of this study is to evaluate the safety and efficacy of nano drug interventional therapy using digital subtraction angiography（DSA） for lung cancer.
- Trial name
- NCT02449122
- Testing
- interventional therapy
- Where
- China
- Volunteers
- 60 people
- Sponsor
- Fuda Cancer Hospital, Guangzhou
Peripheral Arterial Occlusive Disease
Vasovist Magnetic Resonance Angiography (MRA) in Peripheral Arterial Occlusive Disease
This study aims at investigating the diagnostic accuracy of magnetic resonance angiography using the contrast agent Vasovist® in the detection of relevant vascular narrowing of the lower extremity.
- Trial name
- NCT00717639
- Testing
- Diagnostic MR-Angiography
- Where
- 2 sites in Germany
- Volunteers
- 150 people
- Sponsor
- Heidelberg University
Pancreatic Cancer
HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Pancreatic Cancer
The purpose of this study is to evaluate the safety and efficacy of HepaSphere interventional therapy using digital subtraction Angiography（DSA）for pancreatic cancer.
- Trial name
- NCT02449967
- Testing
- interventional therapy
- Where
- China
- Sponsor
- Fuda Cancer Hospital, Guangzhou